Date

22 September 2020

Location

Virtual

Language

English

MedDev Day Virtual

Register Now
MedDev Day Virtual

All times indicated on the Agenda are Central Europe Summer Time.

  At the end of the Conference you can enjoy a relaxing moment with a Singing Live Entertainment!


MedDev Day

Since the Medical Devices Regulation 2017/745 (MDR) entered into force, the MedTech industry has been busy adapting processes, organisational flows and documentation to comply with the new requirements. After the MDR compliance date being postponed by 12 months until May 2021 to respond to COVID-19 limitations, the MedTech industry still needs to focus on managing the final steps of the transition period to align strategies within this new challenging environment. The regulation obliges the industry to meet several goals. Among others:

  • Having an MDR compliant quality system (QMS) in place within the context of remote audit implementation
  • Defining the organisation of a person responsible for regulatory compliance (PRRC)
  • Seeking the acknowledgment of sufficiency of clinical data by notified bodies and competent authorities while managing clinical trials
  • Implementing clinical strategies to meet the requirements of the MDR as regards to clinical development, equivalency approach, sufficiency of clinical data for legacy devices and post market clinical follow up plans and reports
  • Complying with new post market surveillance requirements in the form of Periodic safety update reports (PSURS) and summary of safety and clinical performance (SSCP)

The new Medical Devices Regulation requirements vary significantly depending on the device’s risk class. Being well informed is a must to ensure compliance of legacy products and to plan an appropriate strategy for new CE markings in the pipeline. In this regulatory environment, a clear understanding of the rules, an update on guidance documents and notified bodies activities, as well as the input from industry experience are key to support both, the infrastructure needed to obtain appropriate clinical evidence and the new clinical workload.  

This second edition of the MedDev Day will shed light on the MDR rules a few months before the date of its application with a clinical focus. We will share experiences and real-life examples from notified bodies, competent authorities, and industry on how to cope with regulations. The event will address topics such as: 

  • The EU perspective: Latest developments in MDR implementation regulations, Common Specifications and Clinical Guidance Documents
  • The notified body perspective: Notified body experiences on audits on Medical Devices Quality Management System readiness, and MDR product certification. Lessons learned from past audits including remote audit situation
  • The Industry perspective: how to use the remaining months for MDR readiness and MDD projects
  • Discussions on Common Specifications (CS) for MDR Annex XVI devices without medical purpose. Impact of CS on planning sufficient clinical data
  • The Role of the person responsible for regulatory compliance (PRRC) in the clinical strategy and investigational devices. Liability and risk mitigation
  • How to assess and close gaps in clinical evidence. Challenges in the clinical evaluation and investigation route. The role of post market surveillance clinical data
  • Practical Medical Devices clinical evaluation plans and clinical evaluation documentation per device risk class:

            -     Clinical evaluation plans and clinical investigation plans for class I, II and III products in line with the revised ISO 14155.        
            -     Post market clinical follow up (PMCF) plans and reports for class I, II and III products.                   
            -     Post market surveillance (PMS) documentation, periodic safety update reports (PSURS) and summary of safety and performance characteristics (SSCP) how and what to compile for each device class.

The second edition of the MedDev Day will be a one day fully virtual meeting and will bring together quality, regulatory and clinical expertise from Medical Devices and Pharma industry, CROs, Regulatory Authorities and Academia.


Scientific Board

Francesco Dell’Antonio - Vice President, Regulatory Affairs and Quality Assurance at Quanta System
Laura Michellini - Scientific Director at Contract Research Organizations Latis Srl and Elle Research Srl
Arkan Zwick - Corporate Regulatory Affairs Director at CROMA Pharmaceutical, Austria

Who should attend?

The event is designed for professionals in the field of Medical Devices, devoted to departments such as: Clinical Operations, Product Managers, Regulatory Affairs, Quality Assurance/Control, Risk Management, Medical Device Engineering, Device vigilance, R&D, Medical Affairs, Medical Writing from Pharmaceutical, Biotechnology and Medical Device companies, CROs, Universities/Hospitals, Academic Research, Patient Associations and Healthcare Organizations.


Sponsor


For sponsorship opportunities, please contact events@lsacademy.com

Certificate of attendance

Download the Agenda
Certificate of attendance

22 September 2020

Abstract available soon

Dario Pirovano Dario Pirovano – Senior Regulatory Adviser at MedTech Europe

The coming into force of the new regulation offers opportunities to further document the design and development of the devices. In this section we will talk about the expectation for Technical documentation sampling, rounds of questions, post market clinical data. The postponing of the Date of application gives one year more for manufacturers to either renew MDD/AIMDD certificates and to apply for MDR. Concomitant validity of both MDD/AIMDD certificates and MDR certificates on the same product pose other challenging with respect to manufacturing and post market data we will also discuss in the session.

This session will provide an overview of the ongoing implementation of Medical Devices Regulation (MDR) from a notified body perspective.

Francesco  Laterza Francesco Laterza – Regulatory Lead – Global Oversight at BSI Group – Regulatory Services (Medical Devices)

This presentation will examine the MED-EL experience and learnings on the various parts of this challenging journey: 

  • Internal MDR project set up: a breakdown of the phases of the project, governance, responsibilities and changes over the project lifetime; 
  • Getting QMS system MDR ready: the process to identify gaps in our system and remediate gaps in preparation for the external notified body audit and tips for a successful audit; 
  • Notified body MDR review and learnings: preparation of the technical documentation for Notified Body review, differences in the different classes, tricky GSPR requirements, sample review questions, challenges and solutions;   
  • Transitioning fully to MDR challenges: braving the next frontier of balancing the requirements of both MDD/AIMD and MDR products until 2024/2025.  

Aim of presentation will be provide our MDR project, audit and product review learnings and to share tips and advice on how we navigated certain challenges along the way. 

Elizabeth  Gfoeller Elizabeth Gfoeller – Corporate Director, Regulatory Affairs at MED-EL Elektromedizinische Geraete Gesellschaft m.b.H.

The growing use of devices that do not have a specific purpose in the medical field but that are used both in the professional and private sectors, has pushed the European legislator to insert them in the EU Reg. 745/2017 (MDR) to protect not only the public health but also manufacturers and end users. These devices are specifically identified in Annex XVI of the MDR Regulation and among these are predominant those used in the aesthetic field, such as coloured contact lenses, fillers or other skin injectables (except those used for tattoos), equipment used for liposuction, lipolysis or lipoplasty. 
The manufacturers of devices for aesthetic use, having to fulfil these new obligations, shall start planning an adequate Quality Management System and prepare the Technical Documentation required by the MDR Regulation and adhere to the requirements that will be described within the Common Specifications (CSs).

Melania Battistella Melania Battistella – Global Manager Aesthetic Products at TUV SUD

The new Medical Devices Regulation 2017/745 (MDR) requires manufacturers to appoint a "person responsible for regulatory compliance" (PRRC). Requiring a PRRC is a new legal requirement under the European Union medical device rules and there are many open questions around this new function. The PRRC will have a very broad range of regulatory responsibilities. Effectively, this person will need to oversee and have responsibilities related to almost all regulatory affairs activities in the pre-market and post-market stage of the life-cycle of the medical device, including investigational devices. 

Even though the PRRC is assigned with these important responsibilities, the MDR is rather silent on the question whether and when the PRRC may be personally liable for these activities and any damages resulting therefrom. This presentation will discuss the legal framework of the liability rules that apply to the PRRC and to the medical device manufacturer and will aim to delineate the scenarios when the device manufacturer is liable and when the PRRC may be held liable under civil and criminal laws. The presentation will also discuss practical measures and steps that PRRCs and device manufacturers may take to mitigate their liability risks in the daily business practice.

Adem  Koyuncu Adem Koyuncu – Lawyer and Medical Doctor, Partner of law firm Covington & Burling LLP

Regulation 2017/745 (MDR) puts a much stronger emphasis on Post Market Surveillance compared to the current MDD. We will discuss the PMS plan as central document in the device life cycle, its content and how the data gathered through PMS activities will be reported. A link between the risk management file and trend reporting as outlined in Article 88 of the MDR will be established. The Periodic Safety Update Report (PSUR) for device classes IIa, IIb and III will be discussed in more detail, incl. the use of IMDRF codes for more uniform reporting. 

Ralf Labugger Ralf Labugger – Regulatory Affairs Compliance Manager at Croma-Pharma

Regulation 2017/745 (MDR) and 2017/746 (IVDR) were released with a clear desire to place patients and users of medical device at the center of device development and post-market surveillance. With a strong focus on safety and proactive risk management, the new regulations take device vigilance requirements from guidance into law and will certainly lead to higher oversight by Competent Authorities and Notified Bodies. Companies need to prepare for higher scrutiny without the support of guidance and facing much uncertainty on elements newly introduced by the MDR / IVDR text. While the recent delay in the MDR date of application will allow manufacturers to benefit from additional time to prepare, there is substantial work required and early and proactive readiness will help secure the product portfolio. This presentation shares the lessons learned on preparatory work and certification audit experience for the first successful medical device certificate under Regulation 2017/745 in 2019.

Laura Gámez Laura Gámez – Senior Pharmacovigilance Process Manager at Novartis

managed by Melania Battistella, Global Manager Aesthetic Products at TUV SUD

The lecture will be  followed by an interactive section.

Scientific Board

Francesco  Dell’Antonio
Francesco Dell’Antonio Vice President, Regulatory Affairs and Quality Assurance at Quanta System Spa
Laura Michellini
Laura Michellini Scientific Director at Contract Research Organizations Latis Srl and Elle Research Srl
Arkan Zwick
Arkan Zwick Corporate Regulatory Affairs Director at CROMA Pharmaceutical, Austria

Speakers

Melania Battistella
Melania Battistella Global Manager Aesthetic Products at TUV SUD
Laura Gámez
Laura Gámez Senior Pharmacovigilance Process Manager at Novartis
Elizabeth  Gfoeller
Elizabeth Gfoeller Corporate Director, Regulatory Affairs at MED-EL Elektromedizinische Geraete Gesellschaft m.b.H.
Adem  Koyuncu
Adem Koyuncu Lawyer and Medical Doctor, Partner of law firm Covington & Burling LLP
Ralf Labugger
Ralf Labugger Regulatory Affairs Compliance Manager at Croma-Pharma
Francesco  Laterza
Francesco Laterza Regulatory Lead – Global Oversight at BSI Group – Regulatory Services (Medical Devices)
Dario Pirovano
Dario Pirovano Senior Regulatory Adviser at MedTech Europe

Scientific Board

Francesco  Dell’Antonio
Francesco Dell’Antonio Vice President, Regulatory Affairs and Quality Assurance at Quanta System Spa
Laura Michellini
Laura Michellini Scientific Director at Contract Research Organizations Latis Srl and Elle Research Srl
Arkan Zwick
Arkan Zwick Corporate Regulatory Affairs Director at CROMA Pharmaceutical, Austria

Sponsors

Media Partners

Conference Venue

MedDev Day Virtual

Virtual conference with presentations, slots for Q&A and discussion among delegates.

Useful information

LS Academy will provide the link to join the conference some days before the conference date.

All times indicated on the Agenda are Central Europe Summer Time.

Fee includes: access to the virtual conference, organizational support, certificate of attendance, slide presentations in pdf format provided post-event.

Useful numbers

Ilaria Butta
Ilaria Butta Events & Training Executive
Enrico Pedroni
Enrico Pedroni Managing Director
Valeria Quintily
Valeria Quintily Project & Scientific Manager

Past Events

Conference Price

Ordinary

560.00 €

Payments accepted

  • Bank Transfer
  • Credit Card
  • PayPal

For information:

Contacts:

Ilaria Butta
Ilaria Butta Events & Training Executive
Enrico Pedroni
Enrico Pedroni Managing Director
Valeria Quintily
Valeria Quintily Project & Scientific Manager
Organised by

Technical and scientific training in the
pharmaceutical field
Via Roma 20 – 24022 – Alzano Lombardo (BG)
Tel: +39 035 515684

Participants' Feedbacks

Variety of topics, key messages around clinical impact were detailed well, speakers engaging and knowledgeable

Good organization/logistics, quality of speakers

Positive the combination workshop + conference

Good overview a lot of MDR aspects, possibility to ask questions and exchange with other participants

The speakers were quick open to speak also after the presentation, good mix of speakers

Conference was very well focused on the really problems of the companies in this phase

Well-thought agenda, networking, catering and hotel

Agenda covered a lot of different topics within a day. speakers were very open to answering questions even outside of the session

Organisation great, was very helpful via email prior to the conference (durign registration) 

good group size, good organization

Broad overview of different fields of application, insights into unknown territory conderning MDR

LS Academy by numbers

2000
Active since
1
Trainings
1
Conferences
1
Trained Professionals

Group Rates

Contact us to register more people to benefit from the best discount

Secure payment with

Customer service

Monday - Friday: 9:00 | 13:00 and 14:00 | 18:00
+39.(0)35.515684 - info@lsacademy.com

Close Menu
×
×

Cart

MedDev Day Virtual

information request

MedDev Day Virtual

Sponsorship request

Terms & Conditions

Trainings
The fee includes: tuition, teaching materials, lunches and coffee breaks, organizational office assistance, attendance certificate. Early Bird discount not applicable to Freelance – Academy – Public Administration fee.
The course will proceed with a minimum of 8 participants. Should this number not be reached the registered participants will be notified one week prior to the commencement of the course.
For further information please contact:  e-mail: training@LSAcademy.com  telephone: +39 (0)35.515684

Conferences
The fee includes: seat at the conference, copy of presentations of Speakers who allow the distribution, informative literature for the day, networking lunch, coffee break, organisational office assistance, certificate of attendance. For further information please contact:  e-mail: events@LSAcademy.com  telephone: +39 (0)35.515684

Webinars
The fee includes: tuition, teaching materials, organizational office assistance, attendance certificate. Early Bird discount not applicable to Freelance – Academy – Public Administration fee. For further information please contact:  e-mail: training@LSAcademy.com  telephone: +39 (0)35.515684

Common Terms & Conditions

Terms of payment
Payment should be made online (by credit card) or by bank transfer, at the time of registration (only for Italian companies: + 22% VAT) to EasyB s.r.l by bank transfer or by credit card. Bank transfer payable to:

EasyB S.r.l.
Via Roma, 20 – 24022 Alzano Lombardo (Bergamo)
VAT: IT03633040161
BANCO BPM – Filiale di Carobbio degli Angeli
IBAN: IT81 F 05034 53960 000000003450
SWIFT Code: BAPPIT21AY5

Confirmation of event admission will be given on receipt of payment. Invoice will be sent following receipt of payment. EasyB reserves the right to refuse late registrations or additional registrations above the maximum accepted number of participants or registrations of roles that are not included in the target of the event.

Cancellation
Please note that refunds (50% refund of the registration fee) will only be given if cancellation is received at least four weeks before the event date. Cancellations will only be valid if made in writing. Transfer of registrations (or name changes) are allowed for free and should be made in writing within 7 days prior to the event. EasyB reserves the right to postpone or cancel an event, to change the location of an event or to alter the advertised speakers for an event, to change its performance from residential to webinar/online. EasyB is not responsible for any loss or damage as a result of substitution, alteration, postponement or cancellation of an event due to causes beyond its control including without limitation, acts of God, natural disasters, sabotage, accident, trade of industrial disputes, terrorism, hostilities, epidemics, pandemics, and / or authorities’restrictions (so-called factum principis).

Information collection and use
In accordance with the Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016, we inform you that EasyB S.r.l. (with headquarter in Via Roma 20, Alzano Lombardo, Bergamo, Italy, VAT number IT03633040161), as the data controller, will use your personal data voluntarily provided by you only with the consent and in compliance with the principles dictated by the European Regulations on the protection of personal data for, for the management of participation in the course, for sending the newsletter, and for dissemination purposes. You can read the complete information, including your rights and how to exercise them, following this link.